A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer

2007 ◽  
Vol 30 (3) ◽  
pp. 239-244 ◽  
Author(s):  
Shuanghu Yuan ◽  
Xindong Sun ◽  
Minghuan Li ◽  
Jinming Yu ◽  
Ruimei Ren ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Randomized Study ◽  
Nonsmall Cell Lung Cancer ◽  
Concurrent Chemotherapy ◽  
Stage Iii ◽  
Elective Nodal Irradiation ◽  
Involved Field

scholarly journals Involved-Field Radiotherapy versus Elective Nodal Irradiation in Combination with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Ming Chen ◽  
Yong Bao ◽  
Hong-Lian Ma ◽  
Xiao Hu ◽  
Jin Wang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Randomized Study ◽  
Locally Advanced ◽  
Concurrent Chemotherapy ◽  
Small Cell ◽  
Small Cell Lung ◽  
Elective Nodal Irradiation ◽  
Involved Field ◽  
Involved Field Radiotherapy

This prospective randomized study is to evaluate the locoregional failure and its impact on survival by comparing involved field radiotherapy (IFRT) with elective nodal irradiation (ENI) in combination with concurrent chemotherapy for locally advanced non-small cell lung cancer. It appears that higher dose could be delivered in IFRT arm than that in ENI arm, and IFRT did not increase the risk of initially uninvolved or isolated nodal failures. Both a tendency of improved locoregional progression-free survival and a significant increased overall survival rate are in favor of IFRT arm in this study.

scholarly journals Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer

Cancer ◽  
2011 ◽  
Vol 117 (20) ◽  
pp. 4707-4713 ◽  
Author(s):  
Joe Y. Chang ◽  
Ritsuko Komaki ◽  
Charles Lu ◽  
Hong Y. Wen ◽  
Pamela K. Allen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Proton Therapy ◽  
Nonsmall Cell Lung Cancer ◽  
Concurrent Chemotherapy ◽  
Stage Iii ◽  
High Dose ◽  
Phase 2 ◽  
Unresectable Stage ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document